We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+5.73%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$755M
AUM Growth
-$11.4M
(-1.5%)
Cap. Flow
-$32M
Cap. Flow
% of AUM
-4.24%
Top 10 Holdings %
Top 10 Hldgs %
17.36%
Holding
1,003
New
260
Increased
105
Reduced
226
Closed
411
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$19.9M |
| 2 |
Morgan Stanley
MS
|
+$16.2M |
| 3 |
Dollar General
DG
|
+$13.7M |
| 4 |
TSMC
TSM
|
+$11.7M |
| 5 |
Alibaba
BABA
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$19.4M |
| 2 |
Intel
INTC
|
+$10.4M |
| 3 |
NVIDIA
NVDA
|
+$6.51M |
| 4 |
Zoom
ZM
|
+$6.46M |
| 5 |
Baxter International
BAX
|
+$6.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.74% |
| 2 | Financials | 14.07% |
| 3 | Healthcare | 10.81% |
| 4 | Industrials | 10.04% |
| 5 | Consumer Staples | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
TechTarget
TTGT
$282M
| $421K | 0.06% |
6,066
-2,295
| -27% | -$178K |
|
|
TPTX
327
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $421K | 0.06% |
4,453
-834
| -16% | -$99.2K |
|
328
General Mills
GIS
$19.9B
| $420K | 0.06% |
+6,853
| New | +$395K |
|
|
CVGW
329
DELISTED
Calavo Growers
CVGW
| $417K | 0.06% |
5,366
-923
| -15% | -$70.7K |
|
|
ARGO
330
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $417K | 0.06% |
8,285
-4,851
| -37% | -$227K |
|
331
Albemarle
ALB
$15.5B
| $416K | 0.06% |
+2,845
| New | +$457K |
|
332
Editas Medicine
EDIT
$432M
| $416K | 0.06% |
+9,893
| New | +$564K |
|
333
Heartland Express
HTLD
$911M
| $416K | 0.06% |
21,233
+1,935
| +10% | +$36.7K |
|
334
Citigroup
C
$227B
| $414K | 0.05% |
+5,687
| New | +$380K |
|
335
Camping World
CWH
$635M
| $414K | 0.05% |
+11,376
| New | +$405K |
|
336
Laureate Education
LAUR
$5.13B
| $411K | 0.05% |
+30,251
| New | +$425K |
|
337
Allogene Therapeutics
ALLO
$725M
| $410K | 0.05% |
11,616
-16,438
| -59% | -$554K |
|
|
MDLA
338
DELISTED
Medallia, Inc.
MDLA
| $410K | 0.05% |
+14,684
| New | +$545K |
|
339
Enanta Pharmaceuticals
ENTA
$402M
| $409K | 0.05% |
8,286
-4,568
| -36% | -$228K |
|
340
Intellia Therapeutics
NTLA
$1.68B
| $409K | 0.05% |
5,093
-4,119
| -45% | -$276K |
|
341
Ball Corp
BALL
$16.6B
| $406K | 0.05% |
4,788
-19,284
| -80% | -$1.69M |
|
|
AVYA
342
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $404K | 0.05% |
14,412
-6,200
| -30% | -$166K |
|
343
KT
KT
$8.72B
| $401K | 0.05% |
+32,204
| New | +$365K |
|
344
Antero Midstream
AM
$10.4B
| $400K | 0.05% |
44,289
-10,726
| -19% | -$92.4K |
|
|
DOYU
345
DouYu International Holdings
DOYU
$134M
| $398K | 0.05% |
3,825
-4,535
| -54% | -$614K |
|
|
INVX
346
Innovex International
INVX
$2.04B
| $397K | 0.05% |
11,943
-6,702
| -36% | -$230K |
|
347
Olin
OLN
$2.15B
| $396K | 0.05% |
+10,417
| New | +$316K |
|
348
Honeywell
HON
$77B
| $395K | 0.05% |
+1,931
| New | +$377K |
|
|
AVID
349
DELISTED
Avid Technology Inc
AVID
| $394K | 0.05% |
18,683
+614
| +3% | +$12K |
|
350
Cohen & Steers
CNS
$4.22B
| $393K | 0.05% |
6,008
+2,548
| +74% | +$174K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q1 2021 Portfolio in Review
As of Q1 2021, Aigen Investment Management held 1,003 positions worth $755M, down 1.5% from $766M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Aigen Investment Management withdrew a net $32M in Q1 2021, closing 411 positions and reducing 226 holdings. Its most notable exit was S&P Global, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Aigen Investment Management opened a new position in Splunk Inc worth $17.3M.
- Aigen Investment Management's largest Q1 2021 buy was Splunk Inc: 127,520 shares worth $17.3M.
- Aigen Investment Management added most to Morgan Stanley in Q1 2021, an estimated $16.2M increase.
- Aigen Investment Management's biggest Q1 2021 reduction was Zoom, cutting an estimated $6.46M.
- Aigen Investment Management fully exited S&P Global in Q1 2021, selling an estimated $19.4M.
- Aigen Investment Management's ten largest holdings make up 17% of its $755M portfolio in Q1 2021.
- Aigen Investment Management opened 260 new positions and closed 411 in Q1 2021.
- Aigen Investment Management's portfolio value fell 1.5% quarter-over-quarter to $755M.
Based on Aigen Investment Management's 13F filing for Q1 2021, filed 11 May 2021.